Selskabets formål er at varetage spildevandsforsyningsaktivitet i henhold til den til enhver tid gældende lovgivning herom samt at udføre anden virksomhed, som har en nær tilknytning til spildevandsforsyningsaktivitet. Selskabet skal medvirke til at sikre en spildevandsforsyning af høj sundheds- og miljømæssig kvalitet, der tager hensyn til forsyningssikkerhed og naturen og drives på en effektiv måde, der er gennemsigtig for forbrugerne.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 505.2 mio. | 117.2 mio. | 3.1 mia. | 2.3 mia. | 0 | |
CVR: 25607988
Secondary names: LYNETTEFÆLLESSKABET A/S, VORES RENS LYNETTEFÆLLESSKABET A/S
Previous names: VORES RENS LYNETTEFÆLLESSKABET A/S
2 properties
Upgrade to Pro to see addresses, building data and ownership details
Compared to 246 companies in Opsamling og behandling af spildevand
Comparison is based on industry median values
Lars Green Bach joined the board
Steen Korsgaard Christiansen joined the board
Torben Ole Madsen joined the board
Maja Holt Højgaard joined the board
Finn Robert Feldtmose Andersen left the board
Trine Græse left the board
Jesper Würtzen left the board
Lars Gravgaard Hansen left the board
Peter Michael Fenger joined the board
Karen Kjølbye left the board
Companies in the same industry and area
CVR 25607996
CVR 42993417
CVR 43022539
CVR 70727528
CVR 18283883
The financial health of BIOFOS LYNETTEFÆLLESSKABET A/S appears robust, with a significant increase in revenue and profit in 2024, reaching 505.2 million DKK and 117.2 million DKK, respectively. This marks a notable recovery from a loss in 2022, demonstrating a strong upward trajectory in profitability. The company has maintained a solid equity position, growing from 2.16 billion DKK in 2022 to 2.32 billion DKK in 2024, indicating stability and resilience in the wastewater treatment industry. However, the fluctuating profit margins over the years may warrant attention, as consistent profitability is crucial for long-term sustainability. Overall, BIOFOS is well-positioned within its sector, benefiting from its substantial equity base and recent financial improvements.
AI-generated summary